Clinical Trial Update: Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A clinical trial update examining whether glucagon inhibition modifies the anti-diabetic effect of GLP-1 in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes Mellitus | NA | Status: UNKNOWN